The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Briaseta 10 mg film-coated tablets



Rowex LtdPA0711/305/002

Main Information

Trade NameBriaseta 10 mg film-coated tablets
Active SubstancesAmbrisentan
Dosage FormFilm-coated tablet
Licence HolderRowex Ltd
Licence NumberPA0711/305/002

Group Information

ATC CodeC02KX02 ambrisentan

Status

License statusAuthorised
Licence Issued07/01/2022
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusNot marketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportPDF Version
« Back